Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3199281)

Published in BMC Cancer on October 07, 2011

Authors

Birgitta Grundmark1, Björn Zethelius, Hans Garmo, Lars Holmberg

Author Affiliations

1: Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. birgitta.grundmark@surgsci.uu.se

Articles cited by this

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35

Selenium: biochemical role as a component of glutathione peroxidase. Science (1973) 10.49

Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10

Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 5.04

The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol (2009) 4.73

A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst (2004) 3.32

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst (1998) 2.97

Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res (2005) 1.98

A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila) (2010) 1.92

A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer. Curr Biol (1997) 1.87

Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control (2007) 1.68

Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog (2005) 1.61

Selenium, selenoproteins and human health: a review. Public Health Nutr (2001) 1.59

Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health (2009) 1.54

Prediagnostic serum selenium and risk of cancer. Lancet (1983) 1.54

Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A (2002) 1.45

Protein-protein interactions and posttranslational modifications in mammalian base excision repair. Free Radic Biol Med (2005) 1.42

Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett (2010) 1.35

Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res (2001) 1.34

Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet (2007) 1.33

Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer (2006) 1.31

Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics (2006) 1.29

Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis (2004) 1.29

Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.24

Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res (2008) 1.22

Monitoring micronutrients in cigarette smokers. Clin Chim Acta (2006) 1.21

Measurement of oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-H292 human pulmonary carcinoma cells. Mutat Res (2008) 1.20

The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival. Scand J Urol Nephrol (2005) 1.20

Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer (2003) 1.17

Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res (2002) 1.17

The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. Mol Interv (2009) 1.16

Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study. Circulation (2002) 1.12

Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol (2003) 1.08

Dietary selenium: time to act. BMJ (1997) 1.04

Selenium: epidemiology and basic science. J Urol (2004) 1.04

Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem (2005) 1.04

Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene (2002) 1.03

The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev (2010) 1.02

Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis (2008) 1.01

Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention. Urology (2006) 1.00

Serum selenium determinants in French adults: the SU.VI.M.AX study. Br J Nutr (2006) 1.00

DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 0.99

Potential stages for prostate cancer prevention with selenium: implications for cancer survivors. Cancer Res (2009) 0.97

Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol (2003) 0.95

The Mn-superoxide dismutase single nucleotide polymorphism rs4880 and the glutathione peroxidase 1 single nucleotide polymorphism rs1050450 are associated with aging and longevity in the oldest old. Mech Ageing Dev (2009) 0.83

Serum selenium level and prostate cancer: a case-control study. Nutr Cancer (2008) 0.82

Antioxidants: SELECTed out? Integr Cancer Ther (2009) 0.77

Effect of dietary selenium and vitamin E on the antioxiant defense systems of rat erythrocytes. Int J Vitam Nutr Res (1979) 0.77

Ascorbate interacts with sodium selenite to increase glutathione peroxidase activity in selenium-deficient chick duodena cultured in vitro. Biol Trace Elem Res (1990) 0.77

Selenium metabolism and function. Clin Physiol Biochem (1986) 0.77

Articles by these authors

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2005) 16.35

Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30

Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06

Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst (2008) 8.62

Natural history of early, localized prostate cancer. JAMA (2004) 7.44

Quality of life after radical prostatectomy or watchful waiting. N Engl J Med (2002) 6.83

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol (2011) 5.28

The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol (2009) 4.73

A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med (2009) 3.83

Insulin resistance and risk of congestive heart failure. JAMA (2005) 3.79

Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol (2008) 3.34

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20

Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med (2004) 3.18

Active surveillance for early-stage prostate cancer: review of the current literature. Cancer (2008) 3.18

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ (2006) 3.05

The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer (2002) 2.85

Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol (2013) 2.84

Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ (2009) 2.79

Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol (2011) 2.76

Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol (2011) 2.71

Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden. Lancet Oncol (2010) 2.56

Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst (2010) 2.45

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44

Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden. Eur Urol (2009) 2.37

Breast cancer in young women: poor survival despite intensive treatment. PLoS One (2009) 2.36

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood (2006) 2.36

Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol (2014) 2.35

The Study of Active Monitoring in Sweden (SAMS): a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer. Scand J Urol (2013) 2.29

Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol (2012) 2.28

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. J Clin Oncol (2014) 2.17

Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol (2008) 2.17

Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden. Eur Urol (2011) 2.10

Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol (2007) 1.93

Population-based study on use of chemotherapy in men with castration resistant prostate cancer. Acta Oncol (2013) 1.91

Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. Int J Epidemiol (2012) 1.88

A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res (2012) 1.83

Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med (2006) 1.79

Cardiac troponin-I and risk of heart failure: a community-based cohort study. Eur Heart J (2009) 1.78

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol (2006) 1.76

Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer (2010) 1.74

Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens (2004) 1.73

A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72

A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70

Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative. Circ Cardiovasc Qual Outcomes (2009) 1.67

Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr (2010) 1.64

Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res (2012) 1.63

Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden. J Clin Oncol (2010) 1.62

Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation (2003) 1.62

Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab (2006) 1.61

Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer (2008) 1.54

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open (2012) 1.51

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD). Blood (2008) 1.50

Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care (2010) 1.50

Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer (2005) 1.49

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Eur Urol (2009) 1.49

Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med (2009) 1.48

Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care (2004) 1.47

Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care (2008) 1.41

Prognostic markers under watchful waiting and radical prostatectomy. Hematol Oncol Clin North Am (2006) 1.40

No increased prostate cancer incidence after negative transrectal ultrasound guided multiple biopsies in men with increased prostate specific antigen and/or abnormal digital rectal examination. J Urol (2003) 1.39

Inguinal hernia after radical prostatectomy for prostate cancer: results from a randomized setting and a nonrandomized setting. Eur Urol (2010) 1.39

Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer (2010) 1.31

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD. Blood (2008) 1.30

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. Eur J Cancer (2011) 1.29

Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol (2004) 1.28

Colorectal cancer survival in socioeconomic groups in England: variation is mainly in the short term after diagnosis. Eur J Cancer (2011) 1.27

Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes (2012) 1.27

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort. Cancer Epidemiol Biomarkers Prev (2008) 1.26

Increased incidence of stroke in women with breast cancer. Eur J Cancer (2005) 1.25

Novel metabolic risk factors for heart failure. J Am Coll Cardiol (2005) 1.21

Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care (2006) 1.21